The human breast lobular and ductal structures and the derived tumors from these structures differ substantial in their morphology, microenvironment, biological presentation, functions, and clinical prognosis. Based on these differences, we have proposed that pre-invasive lobular tumors may progress to invasive lesions through "in situ malignant transformation", in which the entire myoepithelial cell layer within a given lobule or lobular clusters undergoes extensive degeneration and disruptions, which allows the entire epithelial cell population associated with these myoepithelial cell layers directly invade the stroma or vascular structures. In contrast, pre-invasive ductal tumors may invade the stroma or vascular structures thr...
PURPOSE: Human invasive breast cancers (IBC) show enormous histologic and biological diversity. This...
Despite the significant biological, behavioural and management differences between ductal carcinoma ...
Background/Aim: Regarding the impact of tumorinfiltrating immune cells on tumor cells, many contradi...
Invasive lobular cancer (ILC) tends to be significantly larger in size with significantly more posit...
Histological and molecular evidence has led to a model of breast cancer progression in which cells f...
Human breast cancer represents a group of highly heterogeneous lesions consisting of about 20 morpho...
Here, we present an experimental model for human luminal progenitor cells that enables single, prima...
SummaryThe transition of ductal carcinoma in situ (DCIS) to invasive carcinoma is a poorly understoo...
Abstract Ductal carcinoma in situ (DCIS) is an intraductal neoplastic proliferation of epithelial ce...
The transition of ductal carcinoma in situ (DCIS) to invasive carcinoma is a key event in breast tum...
The human breast comprises three lineages: the luminal epithelial lineage, the myoepithelial lineage...
Myoepithelial cells (MECs) constitute a continuous layer of cells surrounding the breast glands, loc...
Mixed ductal-lobular carcinomas (MDL) display both ductal and lobular morphology, and are an archety...
Introduction: Lobular carcinoma in situ (LCIS) has been accepted as a marker of risk for the develop...
<div><p>Ductal carcinoma <i>in situ</i> (DCIS) is a heterogeneous group of non-invasive lesions of t...
PURPOSE: Human invasive breast cancers (IBC) show enormous histologic and biological diversity. This...
Despite the significant biological, behavioural and management differences between ductal carcinoma ...
Background/Aim: Regarding the impact of tumorinfiltrating immune cells on tumor cells, many contradi...
Invasive lobular cancer (ILC) tends to be significantly larger in size with significantly more posit...
Histological and molecular evidence has led to a model of breast cancer progression in which cells f...
Human breast cancer represents a group of highly heterogeneous lesions consisting of about 20 morpho...
Here, we present an experimental model for human luminal progenitor cells that enables single, prima...
SummaryThe transition of ductal carcinoma in situ (DCIS) to invasive carcinoma is a poorly understoo...
Abstract Ductal carcinoma in situ (DCIS) is an intraductal neoplastic proliferation of epithelial ce...
The transition of ductal carcinoma in situ (DCIS) to invasive carcinoma is a key event in breast tum...
The human breast comprises three lineages: the luminal epithelial lineage, the myoepithelial lineage...
Myoepithelial cells (MECs) constitute a continuous layer of cells surrounding the breast glands, loc...
Mixed ductal-lobular carcinomas (MDL) display both ductal and lobular morphology, and are an archety...
Introduction: Lobular carcinoma in situ (LCIS) has been accepted as a marker of risk for the develop...
<div><p>Ductal carcinoma <i>in situ</i> (DCIS) is a heterogeneous group of non-invasive lesions of t...
PURPOSE: Human invasive breast cancers (IBC) show enormous histologic and biological diversity. This...
Despite the significant biological, behavioural and management differences between ductal carcinoma ...
Background/Aim: Regarding the impact of tumorinfiltrating immune cells on tumor cells, many contradi...